Search results
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 2 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 2 days agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...
Spotify price increase prompts analysts to retune stock price targets
TheStreet.com· 4 days agoThis is what could happen next to Spotify's shares. Daniel Ek just wanted to clear things up. The Spotify Technology (SPOT) CEO caught all kinds of flak on May 29 when he made a comment on X ...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 5 days agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
Up 400% In 3 Years, Eli Lilly Stock Just Keeps Giving
Forbes· 2 days agoEli Lilly stock (NYSE: LLY) has seen phenomenal gains of 400% from levels of $170 in early 2021 to...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 6 days agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends GSK and Moderna....
6 Dividend Darlings to Keep Your Portfolio Going Amid Choppy Market Action | Investing.com UK
Investing.com· 5 days agoInvestors need to look beyond the headline number before investing for dividends. While the...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 6 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of May 28, 2024 Adria Cimino has no...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...